The 2014 plastic-surgery statistics will be released later today by the American Society for Aesthetic Plastic Surgery (ASAPS). Thanks to an advance peek, I can report that butts are getting bigger, while breasts are getting smaller.
Buttock augmentations are up 86 percent over 2013. Michael C. Edwards, a plastic surgeon and the president of the ASAPS notes that most women don’t want giant backsides, they just want more shapely ones. The other big news is breast revisions, which are up 30.4 percent. Many attribute that rise to aging implants in need of replacement, along with many women’s desire to switch from saline to silicone-gel-filled implants, which may not have been available when they originally had surgery. What’s more, insiders say most of these women are exchanging their old implants for smaller replacements.
The other news in the numbers is a five percent drop in overall procedures: 10,663,607 in 2014, down from 11,419,610 in 2013. The decrease was mostly in minimally-invasive procedures like Botox and fillers. No explanation for this was offered by the ASAPS, but could it be what I call injection fatigue? Many women I’ve spoken to don’t want to return again and again for refills. Surgical procedures fell only 1.5 percent from 1,883,048 to 1,764,956, a drop that the number crunchers say is not statistically significant.
Fat—and getting rid of it—is still a high priority. In recent years the top surgical procedures for women have flipped back and forth between breast implants and liposuction. In 2014, liposuction held the number one spot, followed by breast augmentation (down 8.5 percent), tummy tuck, blepharoplasty (or eye lift), and in fifth place, the breast lift. Facelifts are in eighth place.
Liposuction may still be king (or is it queen?) in the surgical department, but non-surgical fat reduction with devices such as CoolSculpting and VASERshape rose a whopping 42.7 percent, from 94,922 in 2013 to 135,448 in 2014. That number could rise even more this year if ATX-101, an injection for fat reduction under the chin, gets FDA clearance, which it’s expected to receive.